Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype

Journal of Hepatology

Volumn 55, Issue 1, 2011, Pages 111-119

  Frau, Maddalena ^a   Ladu, Sara ^a   Calvisi, Diego F ^a   Simile, Maria M ^a   Bonelli, Piero ^b   Daino, Lucia ^a   Tomasi, Maria L ^a   Seddaiu, Maria A ^a   Feo, Francesco ^a   Pascale, Rosa M ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b EXPERIMENTAL ZOOPROPHYLACTIC INSTITUTE OF SARDINIA   (Italy)

Author keywords

Genetic predisposition; Hepatocarcinogenesis; Mybl2; Transgenic mice

Indexed keywords

CLUSTERIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; PROTEIN MYB; TRANSCRIPTION FACTOR B MYB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYB; GENETIC PREDISPOSITION TO DISEASE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RATS; RATS, INBRED BN; RATS, INBRED F344; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 79958841791     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.10.031     Document Type: Article

References (38)

1. A. Sala MYBL2, a transcription factor implicated in regulating cell cycle, apoptosis and cancer Eur J Cancer 41 2005 2479 2484 (Pubitemid 41540624)
2. R.G. Ramsay, and T.J. Gonda MYB function in normal and cancer cells Nat Rev Cancer 8 2008 523 534 (Pubitemid 351881853)
3. T. Nakajima, K. Yasui, K. Zen, Y. Inagaki, H. Fujii, and M. Minami Activation of Mybl2 by E2F1 in hepatocellular carcinoma Hepatol Res 38 2008 886 895
4. F. Forozan, E.H. Mahlamäki, O. Monni, Y. Chen, R. Veldman, and Y. Jiang Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data Cancer Res 60 2000 4519 4525 (Pubitemid 32103634)
5. P.E. Zondervan, J. Wink, J.C. Alers, J.N. IJzermans, S.W. Schalm, and R.A. de Man Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias J Pathol 192 2000 207 215
6. M.M. Tanner, S. Grenman, A. Koul, O. Johannsson, P. Meltzer, and T. Pejovic Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer Clin Cancer Res 6 2000 1833 1839 (Pubitemid 30305079)
7. X. Mao, G. Orchard, D.M. Lillington, R. Russell-Jones, B.D. Young, and S.J. Whittaker Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas Blood 101 2003 1513 1519 (Pubitemid 36182528)
8. F. Feo, M.R. De Miglio, M.M. Simile, M.R. Muroni, D.F. Calvisi, and M. Frau Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition Biochim Biophys Acta Cancer Rew 1765 2006 126 147
9. R.M. Pascale, M.M. Simile, D.F. Calvisi, M. Frau, M.R. Muroni, and M.A. Seddaiu Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer Hepatology 42 2005 1310 1319 (Pubitemid 43260033)
10. D.F. Calvisi, F. Pinna, S. Ladu, R. Pellegrino, M.R. Muroni, and M.M. Simile Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for human disease Carcinogenesis 29 2008 1639 1647
11. D.F. Calvisi, F. Pinna, S. Ladu, R. Pellegrino, M.M. Simile, and M. Frau Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC Gut 58 2009 679 687
12. D.F. Calvisi, F. Pinna, F. Meloni, S. Ladu, R. Pellegrino, and M. Sini Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated-kinase-mediated control of growth in human hepatocellular carcinoma Cancer Res 68 2008 4192 4200
13. D.F. Calvisi, S. Ladu, F. Pinna, M. Frau, M.L. Tomasi, and M. Sini SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis Gastroenterology 137 2009 1816 1826
14. M. Frau, F. Biasi, F. Feo, and R.M. Pascale Prognostic markers and putative therapeutic targets for hepatocellular carcinoma Mol Aspects Med 31 2010 179 193
15. W. Zhu, P.H. Giangrande, and J.R. Nevins E2Fs link the control of G1/S and G2/M transcription EMBO J 23 2004 4615 4626 (Pubitemid 39657861)
16. A.S. Knight, M. Notaridou1, and R.J. Watson A Lin-9 complex is recruited by Mybl2 to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells Oncogene 28 2009 1737 1747
17. D.B. Solt, A. Medline, and E. Farber Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis Am J Pathol 88 1977 595 618 (Pubitemid 8202940)
18. M. Cervellera, G. Raschella, G. Santilli, B. Tanno, A. Ventura, and C. Mancini Direct transactivation of the anti-apoptotic gene apolipoprotein. J (clusterin) by B-MYB J Biol Chem 275 2000 21055 21060 (Pubitemid 30481795)
19. R.M. Pascale, M.M. Simile, M.R. De Miglio, M.R. Muroni, D.F. Calvisi, and G. Asara Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis Hepatology 35 2002 1341 1350 (Pubitemid 34966888)
20. N. Hanada, H.-W. Lo, -P. Day, Y. Pan, and Y. Nakajima Hung M-C co-regulation of B-Myb expression by E2F1 and EGF receptor Mol Carcinogen 45 2006 10 17 (Pubitemid 43122365)
21. H. Murakami, N.D. Sanderson, P. Nagy, P.A. Marino, G. Merlino, and S.S. Thorgeirsson Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis Cancer Res 53 1993 1719 1723 (Pubitemid 23127090)
22. E.A. Conner, E.R. Lemmer, M. Omori, P.J. Wirth, V.M. Factor, and S.S. Thorgeirsson Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis Oncogene 19 2000 5054 5062
23. S.H. Lau, J.S. Sham, D. Xie, C.H. Tzang, D. Tang, and N. Ma Clusterin plays an important role in hepatocellular carcinoma metastasis Oncogene 25 2006 1242 1250
24. C. Alberti Genetic and microenvironmental implications in prostate cancer progression and metastasis Eur Rev Med Pharmacol Sci. 12 2008 167 175
25. A.R. Thorner, K.A. Hoadley, J.S. Parker, S. Winkel, R.C. Millikan, and C.M. Perou In vitro and in vivo analysis of B-Myb in basal-like breast cancer Oncogene 28 2009 742 751
26. Y. Xu, X. Qu, X. Zhang, Y. Luo, Y. Zhang, and Y. Luo Midkine positively regulates the proliferation of human gastric cancer cells Cancer Lett 279 2009 137 144
27. F. Grise, A. Bidaud, and V. Moreau Rho GTPases in hepatocellular carcinoma Biochim Biophys Acta 1795 2009 137 151
28. D.R. Ganger, P.D. Hamilton, D.J. Klos, S. Jakate, L. McChesney, and J.A. Fernandez-Pol Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia Cancer Detect Prev 25 2001 231 236
29. Y. Takigawa, and A.M. Brown Wnt signaling in liver cancer Curr Drug Targets 9 2008 1013 1024
30. J. Riera, and P.S. Lazo The mammalian NudC-like genes: a family with functions other than regulating nuclear distribution Cell Mol Life Sci 66 2009 2383 2390
31. M.W. Lawless, S. Norris, K.J. O'Byrne, and S.G. Gray Targeting histone deacetylases for the treatment of disease J Cell Mol Med 13 2009 826 852
32. P. Kowalczyk, M. Woszczyñski, and J. Ostrowski1 Increased expression of ribosomal protein S2 in liver tumors, posthepactomized livers, and proliferating hepatocytes in vitro Acta Biochim Polonica 49 2002 615-524
33. M. Wang, Y. Hu, and M.E. Stearns RPS2: a novel therapeutic target in prostate cancer J Exper Clin Cancer Res 28 2009 6
34. B. Cen, H. Li, and I.B. Weinstein HINT1 up-regulates cellular levels of p27KIP1 by targeting SCFSKP2 ubiquitin ligase and SRC J Biol Chem 284 2009 5265 5276
35. M.E. Castro, I. Ferrer, A. Casco, M.V. Guijarro, M. Lleonart, and S. Ramon y Cajal PPP1CA contributes to the senescence program induced by oncogenic Ras Carcinogenesis 29 2008 491 499 (Pubitemid 351404864)
36. S.R. Chintharlapalli, M. Jasti, S. Malladi, K.V. Parsa, R.P. Ballestero, and M. González-García BMRP is a Bcl-2 binding protein that induces apoptosis J Cell Biochem 94 2005 611 626 (Pubitemid 41420296)
37. W. Lei, J.J. Rushton, L.M. Davis, F. Liu, and S.A. Ness Myb transcription factors positive and negative determinants of target gene specificity J Biol Chem 279 2004 29519 29527 (Pubitemid 38915832)
38. J.J. Rushton, L.M. Davis, W. Lei, X. Mo, A. Leutz, and S.A. Ness Distinct changes in gene expression induced by A-Myb B-Myb and c-Myb proteins Oncogene 22 2003 308 313 (Pubitemid 36174188)